Reported Reactions

Devices › Lenses, soft contact, daily wear

Device brand name · Lpl soft contact lens daily wear

Avaira Sphere Enfilcon A: medical device reports filed with FDA

158 reports name it, 2011–2018. Manufacturer given most often on reports: Coopervision Manufacturing. Product code LPL.

158
device reports naming the brand
0% of all MAUDE reports · about 10 a year
0
reports, 12 months to August 2026
0 in the 12 months before
0%
classified as malfunction
4.9% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

158 medical device reports received by FDA name the brand "Avaira Sphere Enfilcon A" (lpl soft contact lens daily wear); the manufacturer given most often on reports is Coopervision Manufacturing; received from June 2011 to December 2018. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all lenses, soft contact, daily wear reports (product code LPL) death is recorded in 0% and malfunction in 4.9%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are insufficient device problem information (69.6%), improper or incorrect procedure or method (3.2%) and device operates differently than expected (2.5%). The patient problems coded most often are corneal ulcer, red eye(s) and blurred vision. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Avaira Sphere Enfilcon A was received in the five years to August 2026; the latest was received in December 2018.

By year received

038762011: 6120112012: 7620122015: 320152016: 820162017: 720172018: 32018

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%158
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%158
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 4,882 reports carrying product code LPL. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Insufficient device problem information11069.6%13.4%
Improper or incorrect procedure or method53.2%2.5%
Device operates differently than expectedthe device behaved unexpectedly42.5%2.9%
Nonstandard device31.9%1.9%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Corneal ulcer3421.5%
Red eye(s)2415.2%
Blurred vision159.5%
Corneal abrasion159.5%
Painpain, site not specified138.2%
Keratitis127.6%
Corneal scar117%
Irritationirritation117%
Intraocular infection85.1%
Conjunctivitispink eye74.4%
Iritis63.8%
Discharge53.2%
Burning sensationa burning feeling42.5%
Scarring42.5%
Bacterial infectiona bacterial infection31.9%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAvaira Sphere Enfilcon AProduct code LPLAll MAUDE reports
Reports1584,88226,136,888
Share of that pool—3.2%0%
Classified as death, per 1,000 reports009
Classified as injury100%90.9%36.2%
Classified as malfunction0%4.9%62.3%
Filed by the manufacturer100%79.4%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code LPL

BrandReportsLatest 12 monthsClassified as death
Acuvue Oasys719270%
Dailies Total 1195120%
Air Optix Night & Day Aqua15190%
Focus Night & Day21500%
Acuvue 217450%
ACUVUE OASYS for ASTIGMATISM261180%
Complete Moisture Plus18800%
AdvanCE22082.7%
Biofinity Toric (comfilcon A)212160%
Amo Complete Moisture Plus17400%
Ciba Vision Memory Lens29400%
Clear Care26400%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Avaira Sphere Enfilcon A reports

How many FDA reports name Avaira Sphere Enfilcon A?

158 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

insufficient device problem information (69.6%), improper or incorrect procedure or method (3.2%), device operates differently than expected (2.5%) and nonstandard device (1.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Avaira Sphere Enfilcon A was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.